Sponsor

Medstar Health Research Institute

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Medstar Health Research Institute appears in 54 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials54
Recruiting shown5
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

54 shown
Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTDNCT07643974 · lead sponsor · 2026-08-01
NOT_YET_RECRUITING
Pilot Study of Intrapartum Insulin PumpNCT07420972 · lead sponsor · 2026-04-01
NOT_YET_RECRUITING
Palliative Care Intervention to Improve Health Related Quality of Life for Patients on Long-Term LVAD SupportNCT07445932 · lead sponsor · 2026-03-01
NOT_YET_RECRUITING
Randomized Evaluation for Failed TAVRNCT06400342 · lead sponsor · 2025-03-01
NOT_YET_RECRUITING
Optimal Pacing Rate for Cardiac Resynchronization TherapyNCT06445439 · lead sponsor · 2023-12-19
UNKNOWN
Reshaping Postpartum Follow-upNCT06054841 · lead sponsor · 2023-05-22
COMPLETED
Socio-Structural Intervention to Improve Pre-Exposure Prophylaxis Services for Cisgender WomenNCT07318532 · lead sponsor · 2023-01-02
COMPLETED
Social Risk Factors and Discrimination in Cancer SurvivorshipNCT05301114 · lead sponsor · 2022-05-05
ACTIVE_NOT_RECRUITING
mHealth for Breast Cancer Survivors With InsomniaNCT05233800 · lead sponsor · 2022-04-05
COMPLETED
Massage Therapy for Self-efficacy in LVAD RecipientsNCT04018508 · lead sponsor · 2021-09-01
TERMINATED
Comorbidities And Reducing inEquitieSNCT04836221 · lead sponsor · 2021-05-05
COMPLETED
The Effect of Personal Protective Aids on Hypertension and Diabetes in People Exposed to High Levels of Air PollutionNCT04854187 · lead sponsor · 2021-03-25
COMPLETED
Assessment of Postpartum Education to Improve ComplianceNCT04486170 · lead sponsor · 2020-09-14
COMPLETED
Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN CancersNCT04626895 · lead sponsor · 2019-06-04
COMPLETED
Personalized Voice Activated Wellness Assistants for Patients With Heart FailureNCT03707275 · lead sponsor · 2018-12-10
COMPLETED
Virtual Reality for Pain Management in Advanced Heart FailureNCT04572425 · lead sponsor · 2018-10-01
COMPLETED
Identification of the Pre-exposure Prophylaxis (PrEP) Cascade for Women.NCT03705663 · lead sponsor · 2018-07-01
COMPLETED
Study to Determine Therapeutic Massage Dosing to Improve Quality of Life in Hospitalized Patients Receiving Palliative CareNCT04916223 · lead sponsor · 2017-11-01
COMPLETED
Use of Negative Pressure Wound Therapy in Morbidly Obese Women After Cesarean DeliveryNCT03269968 · lead sponsor · 2017-10-03
TERMINATED
Medicated Aerosol Delivery Using A Jet Nebulizer Versus A Vibrating Mesh Nebulizer in COPD ExacerbationNCT03051971 · lead sponsor · 2017-03-01
WITHDRAWN
MedStar Diabetes Pathway Chart ReviewsNCT03442595 · lead sponsor · 2016-07-01
COMPLETED
Diabetes to Go: Inpatient Education ImplementationNCT03623607 · lead sponsor · 2016-04-01
COMPLETED
MedStar Health Type 2 Diabetes Pathway to ControlNCT02925312 · lead sponsor · 2014-11-01
COMPLETED
Cardiac Safety Study in Patients With HER2 + Breast CancerNCT01904903 · lead sponsor · 2013-10-01
COMPLETED
Renal Denervation in Patients With Uncontrolled Blood PressureNCT01968785 · lead sponsor · 2013-08-01
TERMINATED
The Synergy to Control Emergency Department Hyperglycemia Program for Type 2 DiabetesNCT02269098 · lead sponsor · 2012-02-01
COMPLETED
Diabetes To Go: An Inpatient Diabetes Survival Skills Education ProgramNCT03023228 · lead sponsor · 2010-05-01
COMPLETED
Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast CancerNCT00810017 · lead sponsor · 2009-02-01
TERMINATED
Stop Emergency Room Visits for Hyperglycemia Project - District of Columbia (DC)NCT01033773 · lead sponsor · 2007-09-01
COMPLETED
Safety, Efficacy, and Pharmacokinetics of Amphotericin B Lipid ComplexNCT01656382 · lead sponsor · 2007-01-01
WITHDRAWN
Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast CancerNCT00397761 · lead sponsor · 2006-07-01
WITHDRAWN
Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for RevascularizationNCT00074724 · lead sponsor · 2003-05-01
COMPLETED
Feasibility and Impact of "ABCs of Diabetes" Self-Management Education Program at an Urban Public LibraryNCT00822471 · lead sponsor · 2003-01-01
COMPLETED
Vinorelbine and Docetaxel in Treating Women With Metastatic Breast CancerNCT00006682 · lead sponsor · 2000-02-01
COMPLETED
Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung CancerNCT00006469 · lead sponsor · 1999-08-01
COMPLETED
RESvEraTrol in Parkinson's Disease (RESET)NCT07592767 · collaborator · 2026-09-17
RECRUITING
Technical Development of Cardiovascular Magnetic Resonance ImagingNCT04927429 · collaborator · 2024-04-08
RECRUITING
Spironolactone for Pulmonary Arterial HypertensionNCT01712620 · collaborator · 2014-01-10
RECRUITING
Prospective Observational Study of the ICD in Sudden Cardiac Death PreventionNCT00733590 · collaborator · 2003-06-01
RECRUITING
Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIVNCT00001281 · collaborator · 1993-03-09
RECRUITING
Pilot Study of Continuous Glucose Monitoring for Postpartum Glucose ScreeningNCT07332416 · collaborator · 2026-07-06
ENROLLING_BY_INVITATION
Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based CohortsNCT04657679 · collaborator · 2021-05-20
TERMINATED
Cooking for HealthNCT03699709 · collaborator · 2020-02-27
COMPLETED
Sexually Active Adolescent Focused EducationNCT03646032 · collaborator · 2019-05-08
COMPLETED
Home Blood Pressure Study for Recent Stroke Survivors With High Blood Pressure *On Hold Due to Global Pandemic*NCT04226157 · collaborator · 2019-02-21
UNKNOWN
A Registry of Intra-Operative Radiation Therapy (IORT) Using the Xoft ® Axxent ® eBx ™ System PatientsNCT03561454 · collaborator · 2019-01-11
ACTIVE_NOT_RECRUITING
Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer PatientsNCT02910219 · collaborator · 2017-01-31
COMPLETED
Ultrathin Bronchoscope and Radial Endobronchial Ultrasound (R-EBUS) With Fluoroscopy Versus Standard Fiberoptic Bronchoscopy (FB) (P00029233 )NCT02146131 · collaborator · 2014-07-01
COMPLETED
Palliative Care in People Living With HIV/AIDS: Integrating Into Standard of CareNCT01775436 · collaborator · 2013-10-13
COMPLETED
Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational DiabetesNCT00572689 · collaborator · 2013-08-01
WITHDRAWN
Stopping TNF Alpha Inhibitors in Rheumatoid ArthritisNCT01793519 · collaborator · 2013-01-01
UNKNOWN
Hemofiltration in Burns: RESCUE (Randomized Controlled Evaluation of Hemofiltration in Adult Burn Patients With Septic Shock and Acute Renal Failure)NCT01213914 · collaborator · 2011-08-01
UNKNOWN
Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes ComplicationsNCT01415115 · collaborator · 2007-03-01
COMPLETED
A Prospective, Randomized, Parallel Crossover Study Demonstrating Subject Wearability and Usability of the I-Port Injection PortNCT00486109 · collaborator · 2006-10-01
COMPLETED

Drugs studied in this sponsor's trials

17 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Medstar Health Research Institute as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
placebo2
trastuzumab2
adalimumab1
capecitabine1
carboplatin1
crofelemer1
docetaxel1
etanercept1
placebo RxCUI 8375 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 2 trials trastuzumab RxCUI 224905 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials adalimumab RxCUI 327361 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial capecitabine RxCUI 194000 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial carboplatin RxCUI 40048 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial crofelemer RxCUI 1364449 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial docetaxel RxCUI 72962 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial etanercept RxCUI 214555 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial etoposide RxCUI 4179 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial exenatide RxCUI 60548 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial gentamicin RxCUI 1596450 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial infliximab RxCUI 191831 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial Lacticaseibacillus rhamnosus GG RxCUI 602811 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial paclitaxel RxCUI 56946 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial pertuzumab RxCUI 1298944 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ribociclib RxCUI 1873916 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial spironolactone RxCUI 9997 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial

Sponsor roles

lead sponsor35
collaborator19
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.